{"adverse_reactions":["Sincerus Florida, LLC adverse reactions AD"],"components":["Active, inactive s"],"effective_time":"20200702","id":"a97c130d-1427-824b-e053-2995a90ad22f","instructions_for_use":["Directions for use a"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1205-2 011054 NIACINAMIDE 4% / SPIRONOLACTONE 5% gel 30 gm s"],"set_id":"a97c130d-1426-824b-e053-2995a90ad22f","spl_product_data_elements":["011054 NIACINAMIDE 4% / SPIRONOLACTONE 5% 011054 NIACINAMIDE 4% / SPIRONOLACTONE 5% NIACINAMIDE NIACINAMIDE SPIRONOLACTONE SPIRONOLACTONE"],"version":"1"}